Showing results (11-20 of 105) with videos related to

Sort By:
Pageof 11
International Journal of Cancer|June 2, 2004
Inhibition of the invasion capacity of carcinoma cells by WX-UK1, a novel synthetic inhibitor of the urokinase-type plasminogen activator systemSuna Ertongur, Stephan Lang, Brigitte Mack, et al.
Plos One|February 6, 2013
Rapid and non-enzymatic in vitro retrieval of tumour cells from surgical specimensBrigitte Mack, Carola Eggert, Katharina Eder, et al.
Cancer Research|February 11, 2010
Heterogeneous nuclear ribonucleoprotein H blocks MST2-mediated apoptosis in cancer cells by regulating A-Raf transcriptionJens Rauch, Eric O'Neill, Brigitte Mack, et al.
Cancer Letters|October 2, 2010
Transketolase-like protein 1 confers resistance to serum withdrawal in vitroDiana Hartmannsberger, Brigitte Mack, Carola Eggert, et al.
Neuroscience Research|May 13, 2009
Increased densities of monocarboxylate transport protein MCT1 after chronic administration of nicotine in rat brainMartin Canis, Brigitte Mack, Olivier Gires, et al.
International Journal of Experimental Pathology|September 15, 2012
MMP7 is a target of the tumour-associated antigen EpCAMSabine Denzel, Brigitte Mack, Carola Eggert, et al.
BMC Cancer|March 13, 2010
Multimodal therapy for synergic inhibition of tumour cell invasion and tumour-induced angiogenesisPamela Zengel, Diana Ramp, Brigitte Mack, et al.
Cancer Biomarkers : Section a of Disease Markers|February 12, 2013
CD133 is a predictor of poor survival in head and neck squamous cell carcinomasMartin Canis, Axel Lechner, Brigitte Mack, et al.
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|November 15, 2012
CD133 induces tumour-initiating properties in HEK293 cellsMartin Canis, Axel Lechner, Brigitte Mack, et al.
Biochemical and Biophysical Research Communications|September 8, 2004
Allogenic antibody-mediated identification of head and neck cancer antigensJens Rauch, Martin Ahlemann, Martina Schaffrik, et al.
Pageof 11